In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Premier Listens to Members

Executive Summary

Premier Inc., the group purchasing organization which took flack from members a year ago, is revamping its laboratory supplies contracting strategy in order to make the selection process more scientific in order to provide greater value to members. Three years after it was formed from the merger of three GPOs, members were complaining about the organization's lack of communication, its pricing, and decisions about vendors that some saw as arbitrary. Premier is implementing a decision matrix to help its 18-member lab committee evaluate vendor proposals and instituting tiered pricing, which correlates the price offered to members to their purchase volumes. In June, Premier launched a service offering labs comparative data on efficiency and cost structure; it is about to start a pilot study to determine the most efficient way of contracting for vendors.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV001475

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel